Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2)

• Status: Completed
• Trial end date: 2005-06-01
• Target enrollment: 0
• Participant gender: All

Summary

In patients with diabetes mellitus type 2 stably adjusted to diet long-term intake of aqueous-ethanolic extract from Hintonia latiflora over more than 12 months leads to a statstically significant amelioration of parameters of glycaemic control (HbA1c, postprandial and fasting glucose) not acchievable with diet alone.

As safety parameters, liver function tests and cardiovascular parameters are to be monitored. Adverse events are to be monitored.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Harras Pharma Curarina GmbH

Criteria

Inclusion Criteria:

• Mild to moderate Diabetes mellitus type 2 stable adjusted to diet

• Minimum duration of diabetic complaints 1 year

• Fasting serum glucose 7-14 mmol/l

• HbA1c max. 12%

• Written consent

Exclusion Criteria:

• Hepatic impairment

• Renal impairment

• Pregnancy